EUREKA Recall (September 2025): Cinnamon

On September 9, 2025, EUREKA INC began a Class II recall. Reason: Elevated levels of lead.

In plain words

What

Cinnamon, Clear Plastic Container, 100G, UPC 6251136 034139

Why

Elevated levels of lead.

Where

California, Michigan.

Distribution as reported to FDA: a total of 11 retail and 1 wholesale customers across two states (California and Michigan)

How serious

Class II: the FDA uses this class for a situation where eating the product may cause temporary or medically reversible health problems, or where the chance of serious health problems is remote.

Status: Ongoing. The recall is still in progress.

What to do

Compare the product name, size, UPC and lot or date codes below with what you have. The FDA Enforcement Report is the official record of this recall; for instructions on returns or refunds, follow the notice or contact EUREKA INC.

Official notice ↗

The recalled product1

FDA recall H-0388-2026 · Class II · Ongoing

Cinnamon, Clear Plastic Container, 100G, UPC 6251136 034139

Codes:
Lot code: Batch No.: 06 B:02, Best by date: May 2026.
Quantity:
32 cases

Recall record

Agency
U.S. Food and Drug Administration (FDA)
Recalling firm
EUREKA INC, Pomona, CA
Recall started
September 9, 2025
FDA Enforcement Report
January 21, 2026
Initiated
Voluntary: Firm initiated
Recall number
H-0388-2026
FDA event ID
97767

Latest food recalls

JXK Enterprises, Inc is voluntarily recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug Viagra, which is not declared on the product label.

Nationwide · Ongoing

All food recalls

Recall details come from the U.S. Food and Drug Administration's Enforcement Reports (through openFDA) and from USDA's Food Safety and Inspection Service recalls and public health alerts, checked daily. MealSlash shows what the agency published and links every recall to its official notice; the notice is the authority. openFDA's note: do not rely on openFDA to make decisions regarding medical care.